Naïve exosomes can be engineered to load drugs into their lumen using two different technologies: passive drug loading and active drug loading. These “drugs” can include RNAs, proteins, and nucleic acids, as well as other payloads. Today, a growing number of companies are using engineered exosomes for therapeutic purposes and studies by these companies have confirmed that exosomes can effectively serve as carrier vehicles for several types of bioactive molecules. Several exosome therapeutics have also entered into clinical testing. [Read more…]
BELIEVER Meats Breaks Ground on Largest Cultivated Meat Production Facility in The World
-
The company’s first U.S. commercial scale production facility is planned at 200,000 square feet, with possible expansion in the future
-
Once fully operational, the facility’s production capacity will be at least 10,000 metric tons (22 million pounds)
-
The project represents an initial planned investment of $123.35 million in Wilson County, North Carolina
Ryne Biotechnology Wins $4M from CIRM to Develop RNDP-001, an iPSC-Derived Dopamine Neuron Progenitor
February 14, 2023, San Diego, California — Ryne Biotechnology, Inc. (Ryne Bio), a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron replacement therapies for neurological disorders, announced that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $4 million Clinical Stage Research Program (CLIN1) grant. This funding will enable the company to advance its lead candidate RNDP-001, an iPSC-derived dopamine neuron progenitor for the treatment of both inherited and idiopathic forms of Parkinson’s disease, through submission of an Investigational New Drug (IND) application within the next 12 months. [Read more…]
EV Biologics Generates Mesenchymal Stem Cell Lines
TAMPA, FL, February 21, 2023 – EV Biologics Corp (OTC PINK:YECO), announced that it has successfully generated several mesenchymal stem/stromal cell (MSC) lines for secretome production and further cell line development. The cell banks were isolated from rigorously screened human donor tissue using xeno-free, serum-free culture media for isolation and expansion, after obtaining informed consent (from donors) for research and development. Analysis of the cell lines confirmed their identity as MSCs according to established criteria. [Read more…]
American Academy of Stem Cell Physicians To Hold Board Examination at Upcoming Annual Meeting
American Academy of Stem Cell Physicians offers Diplomat And Fellowship Certifications on June 2-4, 2023m in Miami, FL
MIAMI, February 26, 2023 – The Board of American Academy of Stem Cell Physicians is the official board certifying body of the American Academy of Stem Cell Physicians. (AASCP). As a nationally recognized academy with a mission to bring like-minded physicians together to increase awareness and education of regenerative medicine, the AASCP is proud to announce the Fellowship and Diplomat certification. [Read more…]
- « Previous Page
- 1
- …
- 129
- 130
- 131
- 132
- 133
- …
- 338
- Next Page »